Related references
Note: Only part of the references are listed.Immunostimulatory effects of radioimmunotherapy
Julie Constanzo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Dose finding of oncolytic combination therapy: Essential to secure the patient's quality of life
Stephanie C. Wuyts et al.
EUROPEAN JOURNAL OF CANCER (2022)
Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
Justin Ferdinandus et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Immune-Checkpoint Blockade Enhances 225Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
Johannes Czernin et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Promising potential of [177Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy-a preclinical study using a syngeneic breast cancer model
Patrycja Guzik et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy
Daan F. Boreel et al.
CLINICAL CANCER RESEARCH (2021)
Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments
Adrien Procureur et al.
CANCERS (2021)
Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment
Vera M. Kho et al.
CELLULAR IMMUNOLOGY (2021)
Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
Ioulia Vardaki et al.
CLINICAL CANCER RESEARCH (2021)
Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer
Alyssa Vito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Combination radionuclide therapy: A new paradigm
Shishu Kant Suman et al.
NUCLEAR MEDICINE AND BIOLOGY (2021)
Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Joroen H. A. Creemers et al.
FRONTIERS IN ONCOLOGY (2021)
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade
Ravi B. Patel et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma
Mengshi Li et al.
CANCERS (2021)
Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma
Andrew L. Lin et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy
Pascale Lejeune et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy
Justin C. Jagodinsky et al.
THERANOSTICS (2021)
PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma
Hannah Dabagian et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma
Andrew L. Lin et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a Lu-177-labeled alpha PD-L1 antibody
Jingyun Ren et al.
THERANOSTICS (2021)
Evaluating the Combination of Radioimmunotherapy and Immunotherapy in a Melanoma Mouse Model
R. Jiao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
Maria Esperanza Rodriguez-Ruiz et al.
NATURE IMMUNOLOGY (2020)
Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer
Joseph Sia et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy
Jacques Rouanet et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
Hiro Sato et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Priming and Propagating Anti-tumor Immunity: Focal Hypofractionated Radiation for in Situ Vaccination and Systemic Targeted Radionuclide Theranostics for Immunomodulation of Tumor Microenvironments
Justin C. Jagodinsky et al.
SEMINARS IN RADIATION ONCOLOGY (2020)
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Phase I study of the Lu-177-DOTA(0)-Tyr(3)-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung
Chul Kim et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Mechanistic Insights into Synergy between Melanin-Targeting Radioimmunotherapy and Immunotherapy in Experimental Melanoma
Mackenzie E. Malo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A review of cancer immunotherapy: from the past, to the present, to the future
K. Esfahani et al.
CURRENT ONCOLOGY (2020)
Cancer Immunotherapy Dosing: A Pharmacokinetic/Pharmacodynamic Perspective
Felicien Le Louedec et al.
VACCINES (2020)
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fucikova et al.
CELL DEATH & DISEASE (2020)
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Martin McLaughlin et al.
NATURE REVIEWS CANCER (2020)
Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity
Jacqueline A. Carozza et al.
NATURE CANCER (2020)
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers
Urs B. Hagemann et al.
CLINICAL CANCER RESEARCH (2019)
Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses
Daisuke Sugiura et al.
SCIENCE (2019)
Ability of Molecular Targeted Radionucleotide Therapy and Anti-CTLA-4 to Prevent Spontaneous Metastases in a Preclinical Lewis Lung Carcinoma Model
R. Brown et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
Thomas Langbein et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
The Reciprocity between Radiotherapy and Cancer Immunotherapy
Yifan Wang et al.
CLINICAL CANCER RESEARCH (2019)
Integrin αvβ3-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacy
Haojun Chen et al.
THERANOSTICS (2019)
Auger electrons for cancer therapy - a review
Anthony Ku et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)
90Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma
Reinier Hernandez et al.
COMMUNICATIONS BIOLOGY (2019)
Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer
Joseph W. Kim et al.
CLINICAL GENITOURINARY CANCER (2018)
Combined VLA-4-Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma
Jaeyeon Choi et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs
Julie M. Diamond et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy
J. D. Nosanchuk et al.
SCIENTIFIC REPORTS (2018)
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Silvia C. Formenti et al.
NATURE MEDICINE (2018)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
Hiro Sato et al.
NATURE COMMUNICATIONS (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
Combination of immune checkpoint inhibitors and radiotherapy: Review of the literature
Alessandro Sindoni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Abscopal Effects and Yttrium-90 Radioembolization
Anish Ghodadra et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
Combining α-particle radiopharmaceutical therapy using Actinium-225 and immunotherapy with anti-PD-L1 antibodies in a murine immunocompetent metastatic breast cancer model
Anders Josefsson et al.
CANCER RESEARCH (2016)
A genetic basis for the variation in the vulnerability of cancer to DNA damage
Brian D. Yard et al.
NATURE COMMUNICATIONS (2016)
Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas' sensitivity to lysis by antigenspecific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation
Anthony S. Malamas et al.
ONCOTARGET (2016)
Activation of local and systemic anti-tumor immune responses by ablation of solid tumors with intratumoral electrochemical or alpha radiation treatments
Yona Keisari et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Antitumor Immunity Induced after α Irradiation
Jean-Baptiste Gorin et al.
NEOPLASIA (2014)
Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor
Yin Wu et al.
DIAGNOSTICS (2013)
RADIATION ENHANCES REGULATORY T CELL REPRESENTATION
Evelyn L. Kachikwu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Tissue expression of PD-L1 mediates peripheral T cell tolerance
ME Keir et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
S Demaria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Share Paper
